Richard H Haubrich (Richard Haubrich)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Coronavirus Disease

Top Venues

Open forum infectious diseases

Journal of comparative effectiveness research

Gilead Sciences Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gilead Sciences Inc

United States

VP, MA Research :: Medical Affairs

Publications

Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre C Kalil, Heng Jiang, EunYoung Lee, Celine Der-Torossian, Mark Thrun, Mark C Berry, Richard H Haubrich, Robert L Gottlieb
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen. Open forum infectious diseases 11 (6) (2024)
Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre C Kalil, Heng Jiang, EunYoung Lee, Celine Der-Torossian, Mark Thrun, Mark C Berry, Richard H Haubrich, Robert L Gottlieb
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen. Open forum infectious diseases 11 (6) (2024)
Stephanie H Read, Artak Khachatryan, Aastha Chandak, Roman Casciano, Paul Hodgkins, Richard H Haubrich, Essy Mozaffari
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations. Journal of comparative effectiveness research 10 (17) (2021)
Gregory D Huhn, Moti Ramgopal, Mamta K Jain, Federico Hinestrosa, David M Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H Ryu, Shuping Jiang, Stephanie Cox, Moupali Das, Thai Nguyen-Cleary, David Piontkowsky, Bill Guyer, Lorenzo Rossaro, Richard H Haubrich
HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. PloS one 15 (1) (2020)